RKL Wealth Management LLC Trims Position in UnitedHealth Group Inc (UNH)
RKL Wealth Management LLC lessened its stake in UnitedHealth Group Inc (NYSE:UNH) by 5.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,041 shares of the healthcare conglomerate’s stock after selling 266 shares during the period. RKL Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,241,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Wells Fargo & Company MN raised its position in UnitedHealth Group by 0.5% in the second quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock worth $1,887,377,000 after purchasing an additional 39,480 shares in the last quarter. Jennison Associates LLC raised its position in UnitedHealth Group by 12.0% in the second quarter. Jennison Associates LLC now owns 6,616,652 shares of the healthcare conglomerate’s stock worth $1,623,329,000 after purchasing an additional 710,745 shares in the last quarter. Summit Trail Advisors LLC raised its position in UnitedHealth Group by 19,286.4% in the first quarter. Summit Trail Advisors LLC now owns 6,228,065 shares of the healthcare conglomerate’s stock worth $6,228,000 after purchasing an additional 6,195,939 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of UnitedHealth Group by 3.5% during the first quarter. American Century Companies Inc. now owns 5,116,815 shares of the healthcare conglomerate’s stock worth $1,094,998,000 after buying an additional 173,074 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. increased its holdings in shares of UnitedHealth Group by 1.3% during the first quarter. Schwab Charles Investment Management Inc. now owns 3,911,833 shares of the healthcare conglomerate’s stock worth $837,133,000 after buying an additional 49,824 shares in the last quarter. Institutional investors and hedge funds own 85.17% of the company’s stock.
In other news, insider Larry C. Renfro sold 19,652 shares of the stock in a transaction that occurred on Friday, June 15th. The shares were sold at an average price of $254.55, for a total transaction of $5,002,416.60. Following the sale, the insider now directly owns 153,679 shares of the company’s stock, valued at $39,118,989.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 10,000 shares of the stock in a transaction that occurred on Wednesday, August 8th. The shares were sold at an average price of $258.83, for a total transaction of $2,588,300.00. Following the sale, the director now directly owns 77,172 shares in the company, valued at $19,974,428.76. The disclosure for this sale can be found here. Insiders have sold 44,829 shares of company stock worth $11,457,829 over the last three months. 0.87% of the stock is owned by insiders.
UNH opened at $262.40 on Tuesday. UnitedHealth Group Inc has a one year low of $186.00 and a one year high of $264.30. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.63. The company has a market cap of $250.59 billion, a PE ratio of 26.06, a P/E/G ratio of 1.55 and a beta of 0.71.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.04 by $0.10. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The business had revenue of $56.09 billion for the quarter, compared to analysts’ expectations of $56.10 billion. During the same period in the prior year, the firm earned $2.46 earnings per share. UnitedHealth Group’s revenue was up 12.1% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group Inc will post 12.72 EPS for the current fiscal year.
UnitedHealth Group declared that its Board of Directors has initiated a share repurchase plan on Wednesday, June 6th that allows the company to repurchase 100,000,000 outstanding shares. This repurchase authorization allows the healthcare conglomerate to purchase shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 18th. Stockholders of record on Friday, September 7th will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Thursday, September 6th. This represents a $3.60 annualized dividend and a dividend yield of 1.37%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.75%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Fundamental Analysis and Choosing Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.